David Hanley

Title: David Hanley - Innovator in Pharmaceutical Compositions

Introduction

David Hanley is a notable inventor based in Brookfield, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug stability and efficacy. His work is characterized by a commitment to improving patient care through advanced medical solutions.

Latest Patents

David Hanley holds 1 patent for his invention titled "Clevidipine nanoparticles and pharmaceutical compositions thereof." This patent describes a pharmaceutical composition that includes clevidipine in a sterile, ready-to-use, physically stable, aqueous dispersion of nanoparticles. This innovative formulation stabilizes clevidipine against the formation of impurities and is suitable for parenteral administration, thereby enhancing its therapeutic potential.

Career Highlights

Throughout his career, David has been associated with Chiesi Farmaceutici S.p.a., a company known for its dedication to developing innovative pharmaceutical products. His work at Chiesi has allowed him to focus on creating solutions that address critical healthcare needs.

Collaborations

David has collaborated with talented professionals in his field, including Rajeshwar Motheram and Akif Emre Tureli. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical technologies.

Conclusion

David Hanley's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in healthcare. His work continues to pave the way for advancements that improve patient outcomes and drug delivery systems.